Development of a Preclinical Therapeutic Model of Human Brain Metastasis with Chemoradiotherapy
出版年份 2013 全文链接
标题
Development of a Preclinical Therapeutic Model of Human Brain Metastasis with Chemoradiotherapy
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 14, Issue 4, Pages 8306-8327
出版商
MDPI AG
发表日期
2013-04-16
DOI
10.3390/ijms14048306
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Brain metastases free survival differs between breast cancer subtypes
- (2012) A Berghoff et al. BRITISH JOURNAL OF CANCER
- Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases
- (2012) Raffaele Addeo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Nanotech Revolution for the Anti-Cancer Drug Delivery through Blood- Brain-Barrier
- (2012) M. Caraglia et al. CURRENT CANCER DRUG TARGETS
- Trial design on prophylaxis and treatment of brain metastases: Lessons learned from the EORTC Brain Metastases Strategic Meeting 2012
- (2012) Matthias Preusser et al. EUROPEAN JOURNAL OF CANCER
- Nanotechnologies: A Strategy to Overcome Blood-Brain Barrier
- (2011) Giuseppe De Rosa et al. CURRENT DRUG METABOLISM
- Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)
- (2011) Gianfranco A. Pesce et al. EUROPEAN JOURNAL OF CANCER
- Comparison of in vitro and in vivo approaches to studying brain colonization by breast cancer cells
- (2011) M. Lorger et al. JOURNAL OF NEURO-ONCOLOGY
- Validation of the new graded prognostic assessment scale for brain metastases: a multicenter prospective study
- (2011) Salvador Villà et al. Radiation Oncology
- Capturing Changes in the Brain Microenvironment during Initial Steps of Breast Cancer Brain Metastasis
- (2010) Mihaela Lorger et al. AMERICAN JOURNAL OF PATHOLOGY
- Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer
- (2010) Antonino Musolino et al. CANCER
- Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
- (2010) P. R. Lockman et al. CLINICAL CANCER RESEARCH
- Phase I/II dose escalation trial of concurrent temozolomide and whole brain radiation therapy for multiple brain metastasis
- (2010) Tom Mikkelsen et al. JOURNAL OF NEURO-ONCOLOGY
- The brain microenvironment and cancer metastasis
- (2010) Isaiah J. Fidler et al. MOLECULES AND CELLS
- Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study
- (2009) S. Siena et al. ANNALS OF ONCOLOGY
- Brain Metastasis: Opportunities in Basic and Translational Research
- (2009) E. A. Maher et al. CANCER RESEARCH
- MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?
- (2009) Ann F. Chambers CANCER RESEARCH
- Real-time imaging reveals the single steps of brain metastasis formation
- (2009) Yvonne Kienast et al. NATURE MEDICINE
- Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases
- (2008) Raffaele Addeo et al. CANCER
- In vitro and In vivo Radiosensitization Induced by the DNA Methylating Agent Temozolomide
- (2008) W. J. Kil et al. CLINICAL CANCER RESEARCH
- Recent Approaches to Improve the Antitumor Efficacy of Temozolomide
- (2008) Lucio Tentori et al. CURRENT MEDICINAL CHEMISTRY
- Preliminary characterization of an experimental breast cancer cells brain metastasis mouse model by MRI/MRS
- (2008) R. V. Simões et al. MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started